Published Date: 07 Mar 2023
There is a strong association between sleep bruxism and temporomandibular joint (TMJ) dysfunction.
Read Full NewsAutomated text message reminders with embedded behavioral nudges are linked to higher colorectal cancer screening completion rates than reminder phone calls from nurses.
Researchers conducted a retrospective cross-sectional analysis of patients diagnosed with de novo metastatic breast cancer to evaluate presentation and treatment differences across three main subtypes.
Advantages include low cost and ease of use in diverse clinical settings.
Despite a lack of safety data, maternal sleep aid use is linked to increased use in young children.
A Madrid primary care group is formalizing art prescriptions, using music, film, and other cultural activities to support mental health, chronic disease care, and social connection.
The EMA has endorsed Aquipta, an oral CGRP receptor antagonist, after it showed superior pain relief vs placebo in treating migraine attacks in adults.
The EMA has recommended label expansions for Inaqovi, Opdivo, and Venclyxto, broadening treatment options in AML, Hodgkin lymphoma, and CLL.
1.
Congresswoman has cancer; the IRS is suing a controversial doctor; and caffeine and teenagers.
2.
More nonsmokers are getting lung cancer: Oncologist explains why
3.
A new mechanism of radioresistance formation demonstrated in lung adenocarcinoma
4.
Researchers study effects of cannabis on sedation, cancer treatment symptoms
5.
A study on lung cancer provides additional proof of the value of screening.
1.
Unpacking the Importance of White Blood Cells (WBCs) in the Body
2.
Understanding the Role of CA 19-9 in Cancer Diagnosis and Treatment
3.
Understanding Pancreatic Cancer: Symptoms, Causes and Risk Factors
4.
Understanding Evans Syndrome: Causes, Symptoms, and Treatment Options
5.
Botulinum Toxins in Oncology: A New Frontier in Chronic Pain Management and Apoptosis Induction
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
2.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
4.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation